• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • CEBINA Reports Positive Findings on Azelastine Potency for COVID-19 americanpharmaceuticalreview
    September 27, 2020
    CEBINA GmbH has announced further positive results in its collaborative COVID-19 drug repurposing project, demonstrating allergy nasal spray medication containing azelastine has potent efficacy against SARS-CoV-2 in a human 3D nasal tissue model.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service